Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, 10x Genomics (TXG) reported revenue of $154.88 million, up 9.8% over the same period last year. EPS came in at -$ 0.36, compared to - $0.50 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 133.25 million, representing a surprise of +16.24%. The company delivered an EPS surprise of +20.00%, with the consensus EPS estimate being -$0.45.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...